The government's push to speed up the delisting of troubled companies is running into legal resistance, industry officials said Sunday. The challenges threaten to complicate efforts to improve the quality of the country's stock market after the number of firms removed from the Korea Exchange (KRX) nearly doubled this year. The Seoul Southern District Court recently granted injunctions sought by KOSPI-listed JooYonTech and Kosdaq-listed KM Pharmaceutical, blocking the KRX from proceeding with their delistings. "Even taking into account the circumstances cited by the defendant, including the possibility that granting the injunction could delay the capital market reforms currently under way, there is a demonstrated need because delisting could harm the plaintiffs' business operations and even threaten their continued existence," the court said. The KRX moved forward the implementation of higher market-capitalization thresholds — 30 billion won ($22.28 million) for KOSPI companies and 20 billion won for Kosdaq firms — to July this year, earlier than the initial January 2027 schedule. The